Abstract: An antitussive composition comprising a pharmaceutically acceptable carrier and from about 4 to about 99 percent by weight of a glaucine compound selected from the group consisting of l-glaucine, d,l-glaucine, the physiologically acceptable salts thereof and mixtures thereof.